Commentary: Multiplex dPCR and SV-AUC are Promising Assays to Robustly Monitor the Critical Quality Attribute of AAV Drug Product Integrity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Commentary: Multiplex dPCR and SV-AUC are Promising Assays to Robustly Monitor the Critical Quality Attribute of AAV Drug Product Integrity
Authors
Keywords
AAV, Biopharmaceutical characterization, PCR, AUC, Critical quality attributes, Genome titer, Genome integrity
Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-04-16
DOI
10.1016/j.xphs.2022.04.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of Viral Genome Encapsidated in Adeno-associated Recombinant Vectors Produced in Yeast Saccharomyces cerevisiae
- (2021) Alvaro Galli et al. MOLECULAR BIOTECHNOLOGY
- Evolving AAV-delivered therapeutics towards ultimate cures
- (2021) Xiangjun He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
- (2021) Thomas Weber Frontiers in Immunology
- Comparison of Analytical Techniques to Quantitate the Capsid Content of Adeno-Associated Viral Vectors
- (2021) Amanda K. Werle et al. Molecular Therapy-Methods & Clinical Development
- Planet of the AAVs: The Spinal Cord Injury Episode
- (2021) Katerina Stepankova et al. Biomedicines
- Comprehensive Size Distribution and Composition Analysis of Adeno-Associated Virus Vector by Multiwavelength Sedimentation Velocity Analytical Ultracentrifugation
- (2021) Takahiro Maruno et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity
- (2020) Ngoc Tam Tran et al. Molecular Therapy-Methods & Clinical Development
- 2D droplet digital PCR as a tool for titration and integrity evaluation of recombinant adeno-associated viral vectors
- (2019) Birei Furuta-Hanawa et al. Human Gene Therapy Methods
- Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences
- (2019) Daan J.A. Crommelin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions
- (2018) Austin L. Daniels et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
- (2017) Qizhao Wang et al. Molecular Therapy-Methods & Clinical Development
- Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry
- (2016) Elizabeth E. Pierson et al. ANALYTICAL CHEMISTRY
- Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
- (2016) Terhi Hermanson et al. Expert Opinion On Drug Safety
- Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events
- (2016) Joseph Kotarek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- An Opportunity for Industry–Academia Partnership: Training the Next Generation of Industrial Researchers in Characterizing Higher Order Protein Structure
- (2016) David L. Bain et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Managing uncertainty: A perspective on risk pertaining to product quality attributes as they bear on immunogenicity of therapeutic proteins
- (2012) Amy S. Rosenberg et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics
- (2010) Satish K. Singh et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started